Public Health Genomics

Papers
(The TQCC of Public Health Genomics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Age-Based Genomic Screening: Pediatric Providers’ Perspectives on Implementation17
Effect of Trust in Science on Parental Reactions to Messaging about Children’s Epigenetics-Related Obesity Risk12
Key outcomes from a stakeholder workshop on genomic newborn screening: recommended next steps for the integration of genomics into public health programs12
Just Dissemination of Genomics-Informed Public Health Applications: Time to Deepen Our Public Engagement Approaches11
Health Literacy and Awareness of Family Health History in the All of Us Research Program10
Charting the Future of Clinical Genomics: An Implementation Science Lens10
Understanding Social, Cultural, and Religious Factors Influencing Medical Decision-Making on BRCA1/2 Genetic Testing in the Orthodox Jewish Community10
<i>MTNR1B</i> rs1387153 Polymorphism and Risk of Gestational Diabetes Mellitus: Meta-Analysis and Trial Sequential Analysis10
Next-Generation Public Health Genomics: A Call to Assess the Equitable Implementation, Population Health Impact, and Sustainability of Precision Public Health Applications8
Facilitating Equitable Access to Genomic Testing for Advanced Cancer: A Combined Intuition and Theory-Informed Approach to Intervention Development and Deployment7
Your Family Connects: A Theory-Based Intervention to Encourage Communication about Possible Inherited Cancer Risk among Ovarian Cancer Survivors and Close Relatives7
Development, Evaluation, and User Testing of a Decision-Making Toolkit to Promote Organizations to Implement Universal Tumor Screening for Lynch Syndrome7
Implementing Genomic Medicine in a Federally Qualified Health Center: Assessing Readiness through a Mixed-Methods Approach6
Impact of <i>PD-L1</i> Gene Polymorphisms and Interactions with Cooking with Solid Fuel Exposure on Tuberculosis6
Workplace Genomic Testing: What Do Company Websites Say about Federal Privacy and Anti-Discrimination Laws?6
What is at stake in genetic newborn screening for rare diseases? – An exploratory qualitative study of parents’ and expectant parents’ concerns in the Screen4Care project6
Associations of GST Gene Polymorphisms and GST Enzyme Activity with the Development of Noise-Induced Hearing Loss in Chinese Han Males6
Evaluating Rural Ethiopian Youths’ Willingness and Competency to Promote Literacy Regarding G × E Influences on Podoconiosis5
Predictors of Women’s Intentions to Communicate Updated Genetic Test Results to Immediate and Extended Family Members5
A Genetic Counselor’s Reflections on Lessons Learned, Challenges, and Successes Experienced during a One-Year Pilot Integration in a Primary Care Clinic5
Public Perspectives on Sharing Profits with Biospecimen Donors5
Results from the Delivery of a Community Health Worker Training to Advance Competencies in Cancer Genomics5
Psychometric Properties of a Culturally Adapted Spanish Version of the Attitudes toward Genomics and Precision Medicine Instrument4
Acknowledgement to Reviewers4
Investigating the Impact of Screen-Sharing Visual Aids during Genomic Results Disclosure via Telehealth in Diverse Families in the TeleKidSeq Pilot Study3
Single Nucleotide Polymorphisms in Orexin-1 and BDNF Receptor Genes are Associated with Increased Risk of Developing Postpartum Depression among Women with Gestational Diabetes Mellitus3
Rethinking Benefit and Responsibility in the Context of Diversity: Perspectives from the Front Lines of Precision Medicine Research3
Sociodemographic and Clinical Characteristics Associated with Genetic Testing among Cancer Survivors: Evidence from Three Cancer Registries3
Who’s on Your Genomics Research Team? Consumer Experiences from Australia3
Variation Exists in Service Delivery: Similarities and Differences in the Provision of a Whole Genome Sequencing Service for Paediatric Rare Disease Patients in the National Health Service in England3
Family Leaders Navigate Burden to Communicate Risk During Cascade Screening after Sudden Cardiac Death in the Young3
Financial Advisers’ and Key Informants’ Perspectives on the Australian Industry-Led Moratorium on Genetic Tests in Life Insurance3
0.14379715919495